Quarterly report pursuant to Section 13 or 15(d)

Notes Payable Related to Acquisitions and Revolving Credit Facility

v3.7.0.1
Notes Payable Related to Acquisitions and Revolving Credit Facility
3 Months Ended
Mar. 31, 2017
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]
Note 4 – Notes Payable Related to Acquisitions and Revolving Credit Facility
 
Summary of Notes Payable Related to Acquisitions, Net of Debt Discount
 
Costs incurred related to securing the Company’s fixed rate debt instruments have been capitalized as a debt discount, net of accumulated amortization, and are netted against the Company’s Notes Payable balance in the accompanying Consolidated Balance Sheet.
 
A detail of the Company’s note payable related to acquisitions, net of debt discount as if March 31, 2017 and December 31, 2016 is as follows:
 
 
 
March 31, 2017
 
December 31, 2016
 
Notes payable related to acquisitions, gross
 
$
39,474,900
 
$
39,474,900
 
Less: Unamortized debt discount
 
 
(1,028,797)
 
 
(1,061,602)
 
Notes payable related to acquisitions, net
 
$
38,446,103
 
$
38,413,298
 
 
A rollforward of the unamortized debt discount balance as of March 31, 2017, that was incurred on the Company’s fixed rate debt, is as follows:
 
Balance as of January 1, 2017, net
 
$
1,061,602
 
Debt discount amortization expense
 
 
(32,805)
 
Balance as of March 31, 2017, net
 
$
1,028,797
 
 
Amortization expense incurred related to the debt discount was $32,805 and $90,241 for the three months ended March 31, 2017 and March 31, 2016, respectively, and is included in the “Interest Expense” line item in the accompanying Consolidated Statements of Operations.
 
Summary of Deferred Financing Costs, Net
 
Costs incurred related to securing the Company’s revolving credit facility have been capitalized as a deferred financing asset, net of accumulated amortization in the accompanying Consolidated Balance Sheet.
 
A rollforward of the deferred financing cost balance as of March 31, 2017, that was incurred on the Company’s revolving credit facility, is as follows:
 
Balance as of January 1, 2017, net
 
$
927,085
 
Additions – revolving credit facility
 
 
769,163
 
Deferred financing cost amortization expense
 
 
(125,867)
 
Balance as of March 31, 2017, net
 
$
1,570,381
 
 
Amortization expense incurred related to the revolving credit facility was $125,867 and zero for the three months ended March 31, 2017 and March 31, 2016, respectively, and is included in the “Interest Expense” line item in the accompanying Consolidated Statements of Operations.
 
Cantor Loan
 
On March 31, 2016, through certain of the Company’s subsidiaries, the Company entered into a $32,097,400 portfolio commercial mortgage-backed securities loan (the “Cantor Loan”) with Cantor Commercial Real Estate Lending, LP (“CCRE”). The subsidiaries are GMR Melbourne, LLC, GMR Westland, LLC, GMR Memphis, LLC, and GMR Plano, LLC (“GMR Loan Subsidiaries”). The Cantor Loan has cross-default and cross-collateral terms. The Company used the proceeds of the Cantor Loan to acquire the Marina Towers (Melbourne, FL) and the Surgical Institute of Michigan (Westland, MI) properties and to refinance the Star Medical (Plano, TX) assets by paying off the existing principal amount of the loan with East West bank in the amount of $9,223,500, and the Company granted a security interest in the Gastro One (Memphis, TN) assets.
 
The Cantor Loan has a maturity date of April 6, 2026 and accrues annual interest at 5.22%. The first five years of the term require interest only payments and after that payments will include interest and principal, amortized over a 30 year schedule. Prepayment can only occur within four months prior to the maturity date, except that after the earlier of (a) 2 years after the loan is placed in a securitized mortgage pool, or (ii) May 6, 2020, the Cantor Loan can be fully and partially defeased upon payment of amounts due under the Cantor Loan and payment of a defeasance amount that is sufficient to purchase U.S. government securities equal to the scheduled payments of principal, interest, fees, and any other amounts due related to a full or partial defeasance under the Cantor Loan.
 
The Company is securing the payment of the Cantor Loan with the assets, including property, facilities, and rents, held by the GMR Loan Subsidiaries and has agreed to guarantee certain customary recourse obligations, including findings of fraud, gross negligence, or breach of environmental covenants by GMR Loan Subsidiaries. The GMR Loan Subsidiaries will be required to maintain a monthly debt service coverage ratio of 1.35:1.00 for all of the collateral properties in the aggregate.
 
No principal payments were made for the three months ended March 31, 2017. The note balance as of March 31, 2017 and December 31, 2016 was $32,097,400. Interest expense was $418,873 for the three months ended March 31, 2017. No interest expense was incurred on this note for the three months ended March 31, 2016.
 
As of March 31, 2017, scheduled principal payments due for each fiscal year ended December 31 are listed below as follows:
 
2017
 
$
-
 
2018
 
 
-
 
2019
 
 
-
 
2020
 
 
-
 
2021
 
 
-
 
Thereafter
 
 
32,097,400
 
Total
 
$
32,097,400
 
 
West Mifflin Note Payable
 
In order to finance a portion of the purchase price for the West Mifflin facility, on September 25, 2015 the Company (through its wholly owned subsidiary GMR Pittsburgh LLC, as borrower) entered into a Term Loan and Security Agreement with Capital One to borrow $7,377,500. The note bears interest at 3.72% per annum and all unpaid interest and principal is due on September 25, 2020. Interest is paid in arrears and interest payments begin on November 1, 2015, and on the first day of each calendar month thereafter. Principal payments begin on November 1, 2018 and on the first day of each calendar month thereafter based on an amortization schedule with the principal balance due on the maturity date. The note may not be prepaid in whole or in part prior to September 25, 2017. Thereafter, the Company, at its option, may prepay the note at any time, in whole (but not in part) on at least thirty calendar days but not more than sixty calendar days advance written notice. The note has an early termination fee of two percent if prepaid prior to September 25, 2018. The note requires a quarterly fixed charge coverage ratio of at least 1:1, a quarterly minimum debt yield of 0.09:1.00, and annualized Operator EBITDAR measured on a quarterly basis of not less than $6,000,000. The Operator is Associates in Ophthalmology, Ltd. and Associates Surgery Centers, LLC. No principal payments were made for the three months ended March 31, 2017. The note balance as of March 31, 2017 and December 31, 2016 was $7,377,500. Interest expense incurred on this note was $68,610 and $69,373 for the three months ended March 31, 2017 and March 31, 2016, respectively.
 
As of March 31, 2017, scheduled principal payments due for each fiscal year ended December 31 are listed below as follows:
 
2017
 
$
-
 
2018
 
 
22,044
 
2019
 
 
136,007
 
2020
 
 
7,219,449
 
Total
 
$
7,377,500
 
 
Amended Revolving Credit Facility
 
On December 2, 2016, the Company, the Operating Partnership, as borrower, and certain subsidiaries (GMR Asheville LLC, GMR Watertown LLC, GMR Sandusky LLC, GMR East Orange LLC, GMR Omaha LLC, and GMR Reading LLC) (such subsidiaries, the “Subsidiary Guarantors”) of the Operating Partnership entered into a senior revolving credit facility (the “Credit Facility”) with BMO Harris Bank N.A., as Administrative Agent, which initially provided up to $75 million in revolving credit commitments for the Operating Partnership. The initial Credit Facility included an accordion feature that provided the Operating Partnership with additional capacity, subject to the satisfaction of customary terms and conditions of up to $125 million, for a total initial facility size of up to $200 million. On March 3, 2017, the Company, the Operating Partnership, as borrower, and the Subsidiary Guarantors of the Operating Partnership entered into an amendment to the Credit Facility with BMO Harris Bank N.A., as Administrative Agent, which increased the commitment amount to $200 million plus an accordion feature that allows for up to an additional $50 million of principal amount subject to certain conditions, for a total facility size of $250 million. The Subsidiary Guarantors and the Company are guarantors of the obligations under the amended Credit Facility. The amount available to borrow from time to time under the amended Credit Facility is limited according to a quarterly borrowing base valuation of certain properties owned by the Subsidiary Guarantors. The initial termination date of the Credit Facility is December 2, 2019 which could be extended for one year in the case that no event of default occurs.
 
Amounts outstanding under the Credit Facility bear annual interest at a floating rate that is based, at the Operating Partnership’s option, on (i) adjusted LIBOR plus 2.00% to 3.00% or (ii) a base rate plus 1.00% to 2.00%, in each case, depending upon the Company’s consolidated leverage ratio. In addition, the Operating Partnership is obligated to pay a quarterly fee equal to a rate per annum equal to (x) 0.20% if the average daily unused commitments are less than 50% of the commitments then in effect and (y) 0.30% if the average daily unused commitments are greater than or equal to 50% of the commitments then in effect and determined based on the average daily unused commitments during such previous quarter.
 
The Operating Partnership is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales. The Operating Partnership must also maintain (i) a maximum consolidated leverage ratio, commencing with the fiscal quarter ending December 31, 2016 and as of the end of each fiscal quarter thereafter, of less than (y) 0.65:1.00 for each fiscal quarter ending prior to October 1, 2019 and (z) thereafter, 0.60:1.00, (ii) a minimum fixed charge coverage ratio of 1.50:1.00, (iii) a minimum net worth of $119,781,219 plus 75% of all net proceeds raised through subsequent equity offerings and (iv) a ratio of total secured recourse debt to total asset value of not greater than 0.10:1.00.
 
During the three months ended March 31, 2017, the Company borrowed $101.2 million against the Credit Facility and made no repayments. As of March 31, 2017 and December 31, 2016, the outstanding the Credit Facility balance was $128.9 million and $27.7 million respectively. For the three months ended March 31, 2017, interest incurred on the Credit Facility was $453,925. No interest expense was incurred for the three months ended March 31, 2016.